Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

A time to celebrate: Autumn graduations
2016-04-07

General graduation information 
Livestreaming

The first series of graduations for the year are upon us. Graduates from all seven faculties, the Business School, and the School of Open Learning at the University of the Free State (UFS) will be celebrating their academic achievements. A total of 3681 qualifications will be conferred at ceremonies on the Bloemfontein Campus from 12 to 15 April 2016.

Sejakhumo Makhetha, daughter of our Vice-Rector: Student Affairs and External Relations, Dr Choice Makhetha, will be among the graduates receiving BA Governance and Political Transformation degrees. Coincidently, Dr Makhetha obtained her PhD in Political Science in 2003 at the UFS. Sejakhumo Makhetha is currently busy with her postgraduate diploma in the same field.

The four-day celebration symbolises the UFS prerogative as an institution to transform lives by producing leaders of tomorrow. Dr Muavia Gallie, Dr Sello Hatang, Dawie Roodt, and Nikiwe Bikitsha are expected to address these future leaders and guests at these ceremonies.

Addressed by the best

On the guest speaker line-up, we have Dr Gallie, a School and District Turnaround Strategist and education activist, who has been identified as one of the 10 Most Impressive Public Leaders for 2015 by the UFS Vice-Chancellor and Rector, Prof Jonathan Jansen. The former Head of Operations, Human Resources and Information and Communication Technology at the South African Council for Educators (SACE) has had more than 30 years of experience in education.

Dr Gallie and Dr Hatang will address graduates of the Faculties of Education, Health Sciences, Law, and Theology on 12 April 2016. Dr Hatang is the Chief Executive of the Nelson Mandela Foundation. In addition to being a founding member of the Advisory Council of the Council for the Advancement of the South African Constitution, Hatang has had the privilege of serving as the Head of Information Communications, and spokesperson for the South African Human Rights Commission as well as Director: South African History Archive at Wits University.

Dawie Roodt, founder, director, and chief economist of the Efficient Group, will speak at the Faculty of Economic and Management Science ceremony on 14 April 2016. This nationally-renowned economist boasts 30 years of experience in monetary and fiscal policy, and is one of the most referenced authors. In 2013, he published Tax, Lies and Red Tape.

As one of South Africa’s leading journalists, Nikiwe Bikitsha will draw on her 20-year career in radio, television, and journalism to address the Faculty of the Humanities graduates on the final day of graduations. Through her passion for Africa’s economic development and women empowerment, the co-founder and CEO of Amargi Media has been a successful Programme Director for UN, IMF and AU-related events.

 

Details of event

Dates: 12, 13, 14, 15 April 2016

Times: 09:00 and 14:30

Venue: Callie Human Centre, Bloemfontein Campus, University of the Free State

 

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept